NDC 0002-8351

LYUMJEV Junior KwikPen

Insulin Lispro-aabc

LYUMJEV Junior KwikPen is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Insulin Lispro.

• Product ID: 0002-8351_19854b4d-3151-4f4e-9d8d-06370db32b50
• NDC: 0002-8351
• Product Type: Human Prescription Drug
• Proprietary Name: LYUMJEV Junior KwikPen
• Generic Name: Insulin Lispro-aabc
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-06-15
• Marketing Category: BLA / BLA
• Application Number: BLA761109
• Labeler Name: Eli Lilly and Company
• Substance Name: INSULIN LISPRO
• Active Ingredient Strength: 100 [iU]/mL
• Pharm Classes: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 0002-8351-05

5 SYRINGE in 1 CARTON (0002-8351-05) > 3 mL in 1 SYRINGE (0002-8351-01)

• Marketing Start Date: 2020-06-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "LYUMJEV Junior KwikPen" or generic name "Insulin Lispro-aabc"

NDC	Brand Name	Generic Name
0002-7726	LYUMJEV	Insulin lispro-aabc
0002-7728	LYUMJEV	Insulin lispro-aabc
0002-8207	LYUMJEV	Insulin lispro-aabc
0002-8228	LYUMJEV	Insulin lispro-aabc
0002-8235	LYUMJEV	Insulin lispro-aabc
0002-8351	LYUMJEV	Insulin lispro-aabc